EGLN2 and diabetic cardiomyopathy: Although our present study implicates a potential involvement of PHD1 in diabetic cardiomyopathy, the direct role of PHD1 in cardiomyocyte metabolic reprogramming of diabetic cardiomyopathy is lacking and warrants further investigation.